{
    "info": {
        "nct_id": "NCT04660929",
        "official_title": "A Phase 1, First in Human Study of Adenovirally Transduced Autologous Macrophages Engineered to Contain an Anti-HER2 Chimeric Antigen Receptor in Subjects With HER2 Overexpressing Solid Tumors",
        "inclusion_criteria": "* HER2-positive recurrent or metastatic solid tumors for which there are no available curative treatment options.\n\n  * Breast cancer and gastric/gastroesophageal junction cancers must have failed approved HER2-targeted agents.\n  * Other HER2-positive tumor types must have failed standard of care therapies, while prior therapy with anti-HER2 drugs is not required.\n* Subject must be willing and able to undergo tumor tissue biopsy procedures\n* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1\n* Subject has adequate bone marrow and organ function\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* HIV, active hepatitis B or hepatitis C infection.\n* Diagnosis of immunodeficiency or chronic exposure to systemic corticosteroid therapy or any other form of immunosuppressive therapy\n* Untreated or symptomatic central nervous system (CNS) metastases or cytology proven carcinomatous meningitis.\n\n  o Subjects with small, asymptomatic CNS metastases that do not require treatment are permitted to enroll.\n* Left ventricular ejection fraction (LVEF) <50% as determined by ECHO or multiple gated acquisition scan (MUGA)\n\nOther protocol-defined Inclusion/Exclusion may apply.\n\nCT-0508 in Combination with Pembrolizumab Substudy Only:\n\nExclusion Criteria:\n\n* Subjects with severe hypersensitivity (â‰¥Grade 3) to pembrolizumab and/or any of its excipients\n* Subjects with an active autoimmune disease that has required systemic treatment in past 2 years (i.e., with use of disease modifying agents, corticosteroids or immunosuppressive drugs).\n* Subjects who have a history of (non-infectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease\n* Subjects who have had an allogeneic tissue/solid organ transplant",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Subject must be willing and able to undergo tumor tissue biopsy procedures",
            "criterions": [
                {
                    "exact_snippets": "Subject must be willing and able to undergo tumor tissue biopsy procedures",
                    "criterion": "willingness to undergo tumor tissue biopsy",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Subject must be willing and able to undergo tumor tissue biopsy procedures",
                    "criterion": "ability to undergo tumor tissue biopsy",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* HER2-positive recurrent or metastatic solid tumors for which there are no available curative treatment options.",
            "criterions": [
                {
                    "exact_snippets": "HER2-positive recurrent or metastatic solid tumors",
                    "criterion": "solid tumors",
                    "requirements": [
                        {
                            "requirement_type": "HER2 status",
                            "expected_value": "positive"
                        },
                        {
                            "requirement_type": "disease status",
                            "expected_value": [
                                "recurrent",
                                "metastatic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "no available curative treatment options",
                    "criterion": "curative treatment options",
                    "requirements": [
                        {
                            "requirement_type": "availability",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Breast cancer and gastric/gastroesophageal junction cancers must have failed approved HER2-targeted agents.",
            "criterions": [
                {
                    "exact_snippets": "Breast cancer ... must have failed approved HER2-targeted agents",
                    "criterion": "breast cancer",
                    "requirements": [
                        {
                            "requirement_type": "prior treatment failure",
                            "expected_value": "failed approved HER2-targeted agents"
                        }
                    ]
                },
                {
                    "exact_snippets": "gastric/gastroesophageal junction cancers must have failed approved HER2-targeted agents",
                    "criterion": "gastric/gastroesophageal junction cancer",
                    "requirements": [
                        {
                            "requirement_type": "prior treatment failure",
                            "expected_value": "failed approved HER2-targeted agents"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Other HER2-positive tumor types must have failed standard of care therapies, while prior therapy with anti-HER2 drugs is not required.",
            "criterions": [
                {
                    "exact_snippets": "Other HER2-positive tumor types",
                    "criterion": "HER2-positive tumor type",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "must have failed standard of care therapies",
                    "criterion": "standard of care therapy",
                    "requirements": [
                        {
                            "requirement_type": "failure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "prior therapy with anti-HER2 drugs is not required",
                    "criterion": "prior therapy with anti-HER2 drugs",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has adequate bone marrow and organ function",
            "criterions": [
                {
                    "exact_snippets": "adequate bone marrow",
                    "criterion": "bone marrow function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "adequate ... organ function",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Subjects with an active autoimmune disease that has required systemic treatment in past 2 years (i.e., with use of disease modifying agents, corticosteroids or immunosuppressive drugs).",
            "criterions": [
                {
                    "exact_snippets": "active autoimmune disease that has required systemic treatment in past 2 years (i.e., with use of disease modifying agents, corticosteroids or immunosuppressive drugs)",
                    "criterion": "autoimmune disease",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "systemic treatment requirement (in past 2 years)",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "o Subjects with small, asymptomatic CNS metastases that do not require treatment are permitted to enroll.",
            "criterions": [
                {
                    "exact_snippets": "small, asymptomatic CNS metastases",
                    "criterion": "CNS metastases",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": "small"
                        },
                        {
                            "requirement_type": "symptoms",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "do not require treatment",
                    "criterion": "CNS metastases",
                    "requirements": [
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Left ventricular ejection fraction (LVEF) <50% as determined by ECHO or multiple gated acquisition scan (MUGA)",
            "criterions": [
                {
                    "exact_snippets": "Left ventricular ejection fraction (LVEF) <50%",
                    "criterion": "left ventricular ejection fraction (LVEF)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 50,
                                "unit": "%"
                            }
                        },
                        {
                            "requirement_type": "assessment_method",
                            "expected_value": [
                                "ECHO",
                                "multiple gated acquisition scan (MUGA)"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "Other protocol-defined Inclusion/Exclusion may apply.",
            "criterions": [
                {
                    "exact_snippets": "Other protocol-defined Inclusion/Exclusion may apply.",
                    "criterion": "other protocol-defined inclusion/exclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "applicability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with severe hypersensitivity (â‰¥Grade 3) to pembrolizumab and/or any of its excipients",
            "criterions": [
                {
                    "exact_snippets": "severe hypersensitivity (â‰¥Grade 3) to pembrolizumab",
                    "criterion": "hypersensitivity to pembrolizumab",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "Grade"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "severe hypersensitivity (â‰¥Grade 3) to ... any of its excipients",
                    "criterion": "hypersensitivity to pembrolizumab excipients",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "Grade"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects who have had an allogeneic tissue/solid organ transplant",
            "criterions": [
                {
                    "exact_snippets": "Subjects who have had an allogeneic tissue/solid organ transplant",
                    "criterion": "history of allogeneic tissue/solid organ transplant",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diagnosis of immunodeficiency or chronic exposure to systemic corticosteroid therapy or any other form of immunosuppressive therapy",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of immunodeficiency",
                    "criterion": "immunodeficiency",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "chronic exposure to systemic corticosteroid therapy",
                    "criterion": "systemic corticosteroid therapy",
                    "requirements": [
                        {
                            "requirement_type": "chronic exposure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "any other form of immunosuppressive therapy",
                    "criterion": "immunosuppressive therapy (other than systemic corticosteroids)",
                    "requirements": [
                        {
                            "requirement_type": "exposure",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* HIV, active hepatitis B or hepatitis C infection.",
            "criterions": [
                {
                    "exact_snippets": "HIV",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "active hepatitis B",
                    "criterion": "active hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hepatitis C infection",
                    "criterion": "hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "CT-0508 in Combination with Pembrolizumab Substudy Only:",
            "criterions": [
                {
                    "exact_snippets": "CT-0508 in Combination with Pembrolizumab Substudy Only",
                    "criterion": "study substudy assignment",
                    "requirements": [
                        {
                            "requirement_type": "assignment",
                            "expected_value": "CT-0508 in Combination with Pembrolizumab Substudy Only"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Untreated or symptomatic central nervous system (CNS) metastases or cytology proven carcinomatous meningitis.",
            "criterions": [
                {
                    "exact_snippets": "Untreated or symptomatic central nervous system (CNS) metastases",
                    "criterion": "central nervous system (CNS) metastases",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "untreated"
                        },
                        {
                            "requirement_type": "symptom status",
                            "expected_value": "symptomatic"
                        }
                    ]
                },
                {
                    "exact_snippets": "cytology proven carcinomatous meningitis",
                    "criterion": "carcinomatous meningitis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis method",
                            "expected_value": "cytology proven"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects who have a history of (non-infectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease",
            "criterions": [
                {
                    "exact_snippets": "history of (non-infectious) pneumonitis/interstitial lung disease that required steroids",
                    "criterion": "pneumonitis/interstitial lung disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": "non-infectious"
                        },
                        {
                            "requirement_type": "treatment_required",
                            "expected_value": "steroids"
                        }
                    ]
                },
                {
                    "exact_snippets": "current pneumonitis/interstitial lung disease",
                    "criterion": "pneumonitis/interstitial lung disease",
                    "requirements": [
                        {
                            "requirement_type": "current",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "line": "Exclusion Criteria:",
            "criterions": []
        }
    ],
    "failed_miscellaneous": []
}